Medical treatment of miscarriage using misoprostol—a retrospective study
Archives of Gynecology and Obstetrics · 2024
DOI: 10.1007/s00404-024-07628-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Laura Meister und 4 weiteren Autor:innen. Beteiligte Einrichtung: Otto-von-Guericke-Universitat Magdeburg, Leibnizstrasse 43, 39104, Magdeburg, Germany. laura.meister@st.ovgu.de. Hauptthemen laut MEDLINE: Misoprostol, Abortifacient Agents, Nonsteroidal, Abortion, Spontaneous. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Otto-von-Guericke-Universität Magdeburg.
Abstract (Originalsprache)
Purpose
The treatment of early miscarriage with medication is effective and low in side effects. Nevertheless, no uniform dosage regimen has yet been established, nor has it been possible to determine whether previous pregnancies and births with their respective modes of delivery play a role in the effectiveness of Misoprostol. This study aimed to find predictive parameters for successful treatment with Misoprostol in early miscarriage.
Methods
In a retrospective study at the Otto von Guericke University Women’s Hospital, records of patients with early miscarriage and medical treatment using Misoprostol from 2018 to 2021 were reviewed for this purpose. The need for a curettage subsequent to treatment was scored as a parameter of failure. The data were analyzed using Statistical Package for the Social Science Version 28.0. The significance level was set to 0.050.
Results
We found that successful therapy with misoprostol was seen in 86% ( n = 114). 14% ( n = 20) of the patients had curettage after taking Misoprostol as advised. Out of 134 women, 16% ( n = 21) reported mild side effects, with nausea as the leading one (9.2% ( n = 12)). Significance was found comparing the measurement of double endometrial stripe thickness after the second cycle of Misoprostol in women with and without curettage after medical treatment (exact value two-sided 0.035 at p < 0.05). A cutoff value at 8.8 mm was calculated using ROC Analysis.
Conclusions
Our results indicate that the treatment of early miscarriage in the first trimester with Misoprostol is effective and has few side effects. The measurement of the endometrial stripe thickness after the second cycle of Misoprostol via transvaginal ultrasound could present a predictive marker during therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otto-von-Guericke-Universitat Magdeburg, Leibnizstrasse 43, 39104, Magdeburg, Germany. laura.meister@st.ovgu.de.
- , Braunschweig, Deutschland. laura.meister@st.ovgu.de.
- Otto-von-Guericke-Universitat Magdeburg, Leibnizstrasse 43, 39104, Magdeburg, Germany.
- , Magdeburg, Deutschland.
- , Halle, Deutschland.
Förderung
- Otto-von-Guericke-Universität Magdeburg
Zitieren
APA
Meister, L., Künnemann, I., Fettke, F., Lux, A., & Ignatov, A. (2024). Medical treatment of miscarriage using misoprostol—a retrospective study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-024-07628-6
Vancouver
Meister L, Künnemann I, Fettke F, Lux A, Ignatov A. Medical treatment of miscarriage using misoprostol—a retrospective study. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-024-07628-6
BibTeX
@article{Meister2024,
author = {Meister, Laura and Künnemann, Ines and Fettke, Franziska and Lux, Anke and Ignatov, Atanas},
title = {Medical treatment of miscarriage using misoprostol—a retrospective study},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
doi = {10.1007/s00404-024-07628-6}
}
EUVIMED